|
|
Volumn 37, Issue 1, 1996, Pages 93-96
|
|
Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients
a
|
|
Author keywords
Advanced breast cancer; Chemotherapy; Elderly patients
|
|
Indexed keywords
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
MITOXANTRONE;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
BONE METASTASIS;
BREAST CANCER;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM METASTASIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DIARRHEA;
DRUG EFFICACY;
DRUG RESPONSE;
FATIGUE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MUCOSA INFLAMMATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SENESCENCE;
SOFT TISSUE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VISCERA;
VOMITING;
AGED;
ANTIDOTES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MITOXANTRONE;
NEOPLASM METASTASIS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 0030047575
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: 10.1007/BF01806636 Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|
